SOURCE: Novo Nordisk A/S

November 24, 2008 08:27 ET

Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - November 24, 2008) - Novo Nordisk A/S - Share repurchase programme

On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008.

Since the announcement as of 17 November 2008, the following transactions have been made under the programme:

Number of Average Transaction shares purchase price value, DKK Accumulated, last announcement 3,626,500 1,032,250,004 17 November 2008 50,000 295.7000 14,785,000 18 November 2008 50,000 287.9700 14,398,500 19 November 2008 50,000 284.8000 14,240,000 20 November 2008 75,000 287.2300 21,542,250 21 November 2008 100,000 275.1500 27,515,000 Accumulated under the programme 3,951,500 1,124,730,754

With the transactions stated above, Novo Nordisk owns a total of 24,918,285 treasury shares, corresponding to 3.9% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,550 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit

Company Announcement no 77 / 2008

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2008. All rights reserved.

Contact Information

  • Further information:


    Outside North America
    Elin K Hansen
    Tel: (+45) 4442 3450
    Email Contact

    In North America:
    Sean Clements
    Tel: (+1) 609 514 8316
    Email Contact


    Mads Veggerby Lausten
    Tel: (+45) 4443 7919
    Email Contact

    Hans Rommer
    Tel: (+45) 4442 4765
    Email Contact

    Kasper Roseeuw Poulsen
    Tel: (+45) 4442 4471
    Email Contact